Sovaprevir( ACH-1625 | ACH1625 | ACH-0141625 )

Catalog No. M10021 CAS No. 1001667-23-7

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Sovaprevir
Note

Research use only, not for human use.
Brief Description

Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.
Description

Sovaprevir (ACH-1625, ACH-0141625) is a potent HCV NS3/4A inhibitor in development for the treatment of hepatitis C.HCV Infection Phase 2 Clinical
In Vitro

——
In Vivo

——
Synonyms

ACH-1625 | ACH1625 | ACH-0141625
Pathway

Microbiology/Virology
Target

HCV
Recptor

HCV
Research Area

Infection
Indication

HCV Infection

CAS Number

1001667-23-7
Formula Weight

799.984
Molecular Formula

C43H53N5O8S
Purity

>98% (HPLC)
Solubility

——
SMILES

O=C([C@H]1N(C([C@@H](CC(N2CCCCC2)=O)C(C)(C)C)=O)C[C@H](OC3=CC(C4=CC=CC=C4)=NC5=CC(OC)=CC=C35)C1)N[C@@]6(C(NS(=O)(C7CC7)=O)=O)[C@H](C=C)C6
Chemical Name

2-Pyrrolidinecarboxamide,N-[(1R,2S)-1-[[(cyclopropylsulfonyl)amino]carbonyl]-2-ethenylcyclopropyl]-1-[(2S)-3,3-dimethyl-1-oxo-2-[2-oxo-2-(1-piperidinyl)ethyl]butyl]-4-[(7-methoxy-2-phenyl-4-quinolinyl)oxy]-, (2S,4R)-

1. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.

Calculator

molnova catalog